Acrobiosystems Co Ltd
SZSE:301080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acrobiosystems Co Ltd
SZSE:301080
|
CN |
|
Source Energy Services Ltd
TSX:SHLE
|
CA |
|
A
|
Aegon NV
MIL:AGN
|
NL |
|
CKD Bio Corp
KRX:063160
|
KR |
|
Y
|
Yuexiu Transport infrastructure Ltd
HKEX:1052
|
HK |
Income Statement
Earnings Waterfall
Acrobiosystems Co Ltd
Income Statement
Acrobiosystems Co Ltd
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
0
|
0
|
|
| Revenue |
322
N/A
|
423
+31%
|
385
-9%
|
410
+6%
|
438
+7%
|
461
+5%
|
474
+3%
|
497
+5%
|
514
+3%
|
534
+4%
|
544
+2%
|
553
+2%
|
575
+4%
|
595
+3%
|
645
+8%
|
686
+6%
|
733
+7%
|
795
+8%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(32)
|
(37)
|
(34)
|
(29)
|
(24)
|
(31)
|
(59)
|
(44)
|
(47)
|
(47)
|
(85)
|
(49)
|
(52)
|
(55)
|
(98)
|
(69)
|
(74)
|
(76)
|
|
| Gross Profit |
290
N/A
|
386
+33%
|
351
-9%
|
381
+9%
|
414
+9%
|
430
+4%
|
415
-3%
|
454
+9%
|
467
+3%
|
487
+4%
|
459
-6%
|
504
+10%
|
523
+4%
|
540
+3%
|
547
+1%
|
616
+13%
|
659
+7%
|
719
+9%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(120)
|
(164)
|
(164)
|
(194)
|
(232)
|
(274)
|
(276)
|
(326)
|
(348)
|
(366)
|
(367)
|
(429)
|
(455)
|
(488)
|
(482)
|
(531)
|
(560)
|
(594)
|
|
| Selling, General & Administrative |
(74)
|
(103)
|
(113)
|
(131)
|
(146)
|
(169)
|
(175)
|
(205)
|
(226)
|
(241)
|
(247)
|
(270)
|
(285)
|
(300)
|
(306)
|
(332)
|
(350)
|
(364)
|
|
| Research & Development |
(43)
|
(57)
|
(54)
|
(70)
|
(84)
|
(107)
|
(101)
|
(120)
|
(124)
|
(120)
|
(105)
|
(133)
|
(143)
|
(153)
|
(141)
|
(171)
|
(177)
|
(179)
|
|
| Depreciation & Amortization |
0
|
0
|
(10)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(3)
|
(4)
|
13
|
6
|
(2)
|
2
|
24
|
(2)
|
2
|
(5)
|
14
|
(26)
|
(27)
|
(36)
|
7
|
(28)
|
(33)
|
(51)
|
|
| Operating Income |
170
N/A
|
222
+30%
|
187
-16%
|
187
+0%
|
182
-2%
|
156
-14%
|
140
-10%
|
127
-9%
|
119
-6%
|
121
+2%
|
91
-25%
|
75
-18%
|
68
-9%
|
52
-24%
|
65
+27%
|
85
+30%
|
99
+16%
|
125
+27%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
9
|
22
|
52
|
73
|
76
|
76
|
74
|
63
|
70
|
71
|
53
|
53
|
60
|
52
|
59
|
59
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
1
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
13
|
(1)
|
(2)
|
(2)
|
(15)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
167
N/A
|
220
+31%
|
195
-11%
|
208
+6%
|
234
+12%
|
242
+3%
|
215
-11%
|
202
-6%
|
191
-5%
|
170
-11%
|
161
-5%
|
146
-9%
|
121
-17%
|
104
-14%
|
125
+20%
|
137
+10%
|
157
+15%
|
183
+17%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(22)
|
(25)
|
(22)
|
(22)
|
(26)
|
(28)
|
(16)
|
(13)
|
(12)
|
(12)
|
(13)
|
(12)
|
(6)
|
2
|
(5)
|
(6)
|
(7)
|
(11)
|
|
| Income from Continuing Operations |
145
|
194
|
173
|
186
|
208
|
214
|
199
|
189
|
179
|
158
|
148
|
134
|
115
|
106
|
120
|
131
|
150
|
173
|
|
| Income to Minority Interest |
0
|
0
|
1
|
1
|
3
|
5
|
5
|
7
|
7
|
8
|
6
|
5
|
4
|
3
|
4
|
3
|
1
|
0
|
|
| Net Income (Common) |
146
N/A
|
195
+34%
|
174
-11%
|
187
+7%
|
211
+13%
|
219
+4%
|
204
-7%
|
195
-4%
|
186
-5%
|
166
-11%
|
154
-8%
|
139
-9%
|
119
-15%
|
109
-8%
|
124
+14%
|
134
+8%
|
151
+13%
|
173
+14%
|
|
| EPS (Diluted) |
0.69
N/A
|
1.15
+67%
|
1.3
+13%
|
1.11
-15%
|
1.24
+12%
|
1.29
+4%
|
0.81
-37%
|
0.77
-5%
|
1.11
+44%
|
0.98
-12%
|
0.91
-7%
|
0.82
-10%
|
0.7
-15%
|
0.64
-9%
|
0.74
+16%
|
0.79
+7%
|
0.9
+14%
|
1.03
+14%
|
|